CONMED Corporation revised earnings guidance for the full year 2024. For the period, the company's revenue is expected to be between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
72.88 USD | +2.41% | +3.07% | -33.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.41% | 2.19B | |
-4.79% | 182B | |
+1.52% | 110B | |
-2.85% | 68.11B | |
+0.88% | 50.53B | |
+9.06% | 44.8B | |
+2.84% | 40.7B | |
+21.13% | 32.25B | |
+2.74% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2024